Check out your Company Bowl for anonymous work chats.
Meet Verily Pre, our platform designed to accelerate AI for precision health. Pre is the cornerstone of our data and tech infrastructure, transforming complex, multimodal healthcare datasets for use in healthcare AI. It includes three complementary solutions: ❇️ Refinery: Our powerful curation engine for structured, research and AI-ready data assets ❇️ Exchange: A centralized forum for sharing and accessing datasets, models, and agents ❇️ Workbench: Our highly scalable trusted research environment used by over 20K researchers today
🔮 What’s your prediction for health AI in 2026? Our Chief Product Officer, Myoung Cha, weighed in on the STAT AI Prognosis predictions, foreseeing a big shift: a majority of patients will use AI before a doctor visit. Read more expert predictions from Brittany Trang and see what’s on your own bingo card for the future of health tech.
"With NVIDIA's cutting-edge AI capabilities now available in our Verily Pre platform, we are providing researchers with unparalleled tools to enhance the speed and efficiency of AI model development and omics analysis, ultimately accelerating the understanding of disease and advancing precision health for everyone." - Stephen Gillett, Verily CEO If you’ll be at the J.P. Morgan Healthcare Conference next week, you can hear more from Stephen Gillett on Tuesday, January 13 at 5:30 PM PT at the Westin Saint Francis in San Francisco.
What if you could connect health data to better predict and prevent negative outcomes, and make care more precise? Watch to see how Verily Pre can help get you there.
Our CEO Stephen Gillett will be at the J.P. Morgan Healthcare Conference discussing Verily's business updates and how Verily Pre, our precision health platform, is enabling healthcare AI for our customers and users. 🗓️ Tuesday, January 13th at 5:30 PM PT 📍 Westin St. Francis, Mission Bay Room, San Francisco, CA
What better way to kick off 2026 than at the CES Digital Health Summit! Vindell Washington, our Chief Clinical Officer, will join fellow experts Aliza Silver, JD MPH, Benjamin Zaniello, MD MPH, and Meg Barron at the Health Industry Leaders Forum to discuss the future of health care. They’ll explore the role technology will play, including opportunities and challenges. If you’re attending, join the discussion today, January 5 at 2:20 PM PT.
As 2025 comes to a close, we want to pause and express our deep gratitude for our customers, partners and employees. We're energized by the opportunities ahead to create meaningful impact in healthcare together. Merry Christmas and happy holidays! Wishing you a joyful season filled with peace, happiness, and success in the coming year. Please note that our offices will be closed starting December 24 through January 1. We’ll see you at the start of 2026 🎊
While healthcare is rapidly accelerating the development of LLM-based health agents, the industry still lacks a standardized way to measure how effectively these models retrieve and reason over actual FHIR data. In collaboration with the Massachusetts Institute of Technology and Korea Advanced Institute of Science and Technology, Verily created FHIR-AgentBench — a rigorous, open-source framework to evaluate how AI retrieves and reasons over complex patient records — establishing a new standard for building safer, more reliable health AI systems. The Result? We moved the needle, increasing accuracy from 50% to 80% on complex clinical question-answering tasks. We’re open-sourcing the benchmark to help the industry build more reliable, high-fidelity AI systems for precision health. Read the full technical deep-dive from Verily Senior Data Scientist Jong Ha L. and Data Scientist Eléa Bach.
It’s not enough to simply detect pathogens in wastewater; public health leaders need to understand how they move to make informed decisions. Our partner team at Bangor University is utilizing advanced models to simulate how viruses disperse from rivers to coastal waters. This data creates spatial risk maps, helping governments visualize contamination zones and anticipate outbreaks, even during extreme weather events. Verily is translating these models into clearer, smarter risk assessments for public health: https://viraqua.uk/en/our-science/models
We are thrilled to announce that in collaboration with the Broad Institute of MIT and Harvard, DataTecnica, Northwestern University Feinberg School of Medicine, Sage Bionetworks, Technome, and Vanderbilt University Medical Center, Verily has secured a two-year renewal for the NIH System Biology (SysBio) award. This $9.2 million in continued funding will further the development and implementation of the FAIRplex platform, empowering researchers to efficiently find, access, and analyze data from Accelerating Medicines Partnership® (AMP®) projects and beyond. The platform will help foster a deeper understanding of the systems biology underpinning human health and disease. "This renewed funding underscores the critical importance of creating a unified, accessible, and secure data ecosystem as researchers look to apply advanced AI and machine learning techniques to accelerate scientific findings," says Andrew Trister, MD, PhD, Chief Medical and Scientific Officer at Verily.
